Veterinary Medicines

VITAMINS AD3E/ANAFASIS, ενέσιμο ελαιώδες διάλυμα για βοοειδή, ιπποειδή, χοίροι, αίγες, πρόβατα, νεαροί σκύλοι

Authorised
  • TOCOPHERYL ACETATE
  • Colecalciferol
  • Retinol palmitate
Download as PDF

Product identification

Medicine name:
VITAMINS AD3E/ANAFASIS, ενέσιμο ελαιώδες διάλυμα για βοοειδή, ιπποειδή, χοίροι, αίγες, πρόβατα, νεαροί σκύλοι
Active substance:
  • TOCOPHERYL ACETATE
  • Colecalciferol
  • Retinol palmitate
Target species:
  • Cattle
  • Pig
  • Horse
  • Sheep
  • Goat
  • Dog
Route of administration:
  • Intramuscular and intravenous use

Product details

Active substance and strength:
  • TOCOPHERYL ACETATE
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Colecalciferol
    25000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Retinol palmitate
    50000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular and intravenous use
    • Cattle
      • Meat and offal
        231
        day
      • Milk
        120
        hour
    • Pig
      • Meat and offal
        200
        day
    • Horse
      • Meat and offal
        231
        day
      • Milk
        120
        hour
    • Sheep
      • Meat and offal
        200
        day
      • Milk
        120
        hour
    • Goat
      • Meat and offal
        200
        day
      • Milk
        120
        hour
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11JA
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Uplab Pharmaceutical Company Ltd.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 85823/14-12-2015/K-0002902
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."